Ragosa Mark Insider Trades

Insider Trading History

Track insider trading activity for Ragosa Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1M 16,154 shares
Last Trade
Apr 07, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$63.8k 1,303 shares
$48.94
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.08M 17,457 shares
Last Trade
Apr 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 2,694 shares
$48.94
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Apr 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 2,694 shares
$48.94
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.07M 17,273 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$250k 5,187 shares
$48.13
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $915k 14,763 shares
Last Trade
Apr 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$121k 2,510 shares
$48.13
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $343k 5,536 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$250k 5,187 shares
$48.13
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.93M 31,150 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.63M 54,550 shares
$48.13
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.41M 22,790 shares
Last Trade
Mar 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 36,722 shares
$46.74
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.91M 30,827 shares
Last Trade
Mar 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.69M 36,722 shares
$45.92
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $3.03M 48,808 shares
Last Trade
Mar 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 36,722 shares
$46.74
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.86M 29,931 shares
Last Trade
Feb 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$481k 10,845 shares
$44.35
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$481k 10,845 shares
$44.35
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.29M 20,817 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$772k 17,845 shares
$43.28
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.18M 19,086 shares
Last Trade
Jan 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$503k 12,000 shares
$41.89
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $869k 14,016 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.79M 42,841 shares
$41.67
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.93M 31,086 shares
Last Trade
Dec 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.78M 42,841 shares
$41.49
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $4.58M 73,927 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.79M 42,841 shares
$41.67
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $3.16M 50,986 shares
Last Trade
Nov 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$808k 19,900 shares
$40.58
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Nov 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$808k 19,900 shares
$40.58
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
CHIEF FINANCIAL OFFICER
Holding Value $1.93M 31,086 shares
Last Trade
Nov 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$815k 19,900 shares
$40.94
$61.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up